| 10:00 | Registration and coffee | |
| 10:45 | Welcome | Dr Liz Roberts, AstraZeneca Dr Chris Mathes, Metrion |
| Session chair: Dr Chris Mathes, Metrion | ||
| 11:00 | Excitability and electrical activity in neuroendocrine cancer cells | Prof Hugh Robinson, University of Cambridge |
| 11:35 | Automated Electrophysiology in Drug Discovery | Dr Kelly Gatfield, GSK |
| 12:10 | Networking lunch with posters | |
| Session chair: Dr Ali Obergrussberger, Nanion Technologies | ||
| 13:30 | Don't be too hasty with your ion channel safety | Dr Saïd El Haou, AstraZeneca |
| 14:05 | Endo-lysosomal cation channels TRPML1 and TPC2 as targets for neurodegenerative disease treatment | Prof Christian Grimm, University of Munich |
| 14:40 | Validating functional effects of antibody toxin fusions against sodium channels | Dr Alex Haworth, Metrion Biosciences |
| 15:00 | Break with posters | |
| Session chair: Dr Katie Puddefoot, Metrion Biosciences | ||
| 15:45 | Ion selectivity switching in a lysosomal ion channel | Prof Sandip Patel, University College London |
| 16:20 | Mechanistic relationships in the TMEM16 family of Ca2+ activated ion channels and lipid scramblases | Dr Raimund Dutzler, University of Zurich |
| 16:55 | Closing remarks and poster prizes awarded | |
| 17:10 to 18:30 | Drinks reception and pizza | |